Wednesday, March 16, 2011

Medical News

Medical News


Microparticles help identify early emphysema

Posted: 16 Mar 2011 05:00 PM PDT

Measuring blood levels of endothelial microparticles, which are small vesicles released from activated or apoptotic endothelial cells, may help identify early emphysema, say researchers.

Processing inflexibility may underlie cognitive deficits in schizophrenia

Posted: 16 Mar 2011 05:00 PM PDT

Patients with schizophrenia have difficulty processing information when it requires a global strategy and instead show a preference for focusing on details, study results show.

Study confirms ‘pathophysiological distinctions’ in bipolar disorder, MDD

Posted: 16 Mar 2011 05:00 PM PDT

There are subtle but significant differences in gray matter architecture between patients with bipolar disorder and those with major depressive disorder who both present with psychotic features at a similar early disease stage, study results show.

Remote-controlled microcarriers can deliver cancer drugs directly to tumors

Posted: 15 Mar 2011 05:00 PM PDT

Canadian research results show that doxorubicin can be successfully administered to specific areas of a rabbit's liver using doxorubicin-loaded magnetic microcarriers guided by a magnetic resonance imaging system.

Weight-loss counseling by nurse practitioners no more effective than usual care

Posted: 15 Mar 2011 05:00 PM PDT

Researchers suggest that counseling delivered by general practitioners as part of usual care is sufficient for weight gain reduction in overweight and obese patients, after finding no additional benefits from lifestyle counseling provided by trained nurse practitioners.

Link between hsCRP, the metabolic syndrome varies by ethnicity

Posted: 15 Mar 2011 05:00 PM PDT

Study findings suggest that high-sensitivity C-reactive protein levels are elevated among adolescents with the metabolic syndrome, but that the degree of elevation varies by ethnicity.

Linagliptin shows preliminary promise in Type 2 diabetes

Posted: 15 Mar 2011 05:00 PM PDT

The dipeptidyl peptidase-4 inhibitor linagliptin has shown promise for controlling glucose levels in patients with Type 2 diabetes, results of a phase II study suggest.

Literature review supports metformin as first-line diabetes drug

Posted: 15 Mar 2011 05:00 PM PDT

A major review of diabetes medications supports the use of metformin as a first-line agent, but has failed to demonstrate superior efficacy of any particular two-drug combination with respect to glucose control.

Lymphocyte levels may predict HF mortality risk

Posted: 15 Mar 2011 05:00 PM PDT

Study findings indicate that the total lymphocyte count in heart failure patients is inversely associated with their 5-year mortality risk.

Prompt treatment negates restenosis impact

Posted: 15 Mar 2011 05:00 PM PDT

Results from a Korean study show that almost one-fifth of patients who receive drug-eluting stents for unprotected left main coronary artery disease experience in-stent restenosis.

No comments:

Post a Comment